Online Program

Rhodiola rosea, a medicinal herb for stress, mild to moderate depression and neuro-protection

Wednesday, November 6, 2013 : 9:30 a.m. - 9:50 a.m.

Richard P Brown, MD Board Certified Psychiatrist, Consultation Liaison Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY
Patricia Gerbarg, M.D., Department of Psychiatry, New York Medical College, Kingston, NY
Rhodiola rosea is an ancient medicinal herb used to combat stress, fatigue, anxiety, depression, and cognitive impairment, including brain injury. It can also promote strength, endurance, and physical and mental performance. When combined with tricyclic antidepressants, rhodiola use has been associated with reduction in antidepressant side effects, particularly fatigue and sexual dysfunction, as well as an improvement in depressive symptoms. Gerbarg and Brown find that in their clinical experience rhodiola can be beneficial in attention deficit disorder, chronic fatigue syndrome, fibromyalgia, and recovery from Lyme Disease, since it activates cognition and tends to improve accuracy, alertness and attention. Iovieno et al. note that rhodiola is effective in treating physical exhaustion, decreased motivation, daytime sleepiness, decreased libido, sleep disturbances, and cognitive complaints such as concentration deficiencies, forgetfulness, decreased memory, susceptibility to stress, and irritability. Rhodiola has an excellent safety profile. Side effects are uncommon and mild, and drug interactions are few and easily managed. Dr. Gerbarg will discuss the history, research, and clinical applications of Rhodiola rosea.

Learning Areas:

Advocacy for health and health education
Basic medical science applied in public health
Chronic disease management and prevention
Clinical medicine applied in public health

Learning Objectives:
Describe use, drug interactions, side effects and promising practice in the use of Rhodiola rosea. List three mental health conditions that may be addressed with Rhodiola rosea

Keyword(s): Mental Health, Herbal Medicine

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I co-authored the first review of Rhodiola rosea in the English language in 2002 and have since written numerous chapters and scientific articles on its medical uses, history, and pharmacology, as well as research reviews. I am a psychopharmacologist and have treated patients with R. rosea for over 15 years. As an expert on medicinal herbs, I have included R. rosea in many of my lectures at the American Psychiatric Association and other professional meetings.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.